Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | APro Co Ltd (262260.KQ) | XKOS | KR | 2022-12-31 | 2 days ago | KRW | 12,430.00 | 0.00 | 0.00% | 1,641.08 | 13.20% | NCAV (Net-Net) | 1,641.08 | 13.20% |
| 102 | Aprogen Biologics Inc (003060.KS) | XKRX | KR | 2023-12-31 | 2 days ago | KRW | 1,631.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 103 | Aprogen Healthcare & Games Inc (109960.KQ) | XKOS | KR | 2023-12-31 | 2 days ago | KRW | 638.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 104 | Aprogen Inc (007460.KS) | XKRX | KR | 2023-12-31 | 2 days ago | KRW | 1,555.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 105 | Aprogen KIC Inc (7460.KS) | 2019-12-31 | 3 years ago | KRW | 2,080.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 106 | Aprogen Pharmaceuticals Inc (3060.KS) | 2019-12-31 | 3 years ago | KRW | 1,375.00 | 0.00 | 0.00% | 344.86 | 25.08% | NCAV (Net-Net) | 344.86 | 25.08% | ||
| 107 | APS Holdings Corp (54620.KQ) | 2019-12-31 | 3 years ago | KRW | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 108 | APS Inc (054620.KQ) | XKOS | KR | 2023-12-31 | 2 days ago | KRW | 6,910.00 | 14,358.47 | 207.79% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 109 | AptaBio Therapeutics Inc (293780.KQ) | XKOS | KR | 2021-12-31 | 3 days ago | KRW | 6,010.00 | 0.00 | 0.00% | 924.84 | 15.39% | Ungraded | 0.00 | 0.00% |
| 110 | Aptamer Sciences Inc (291650.KQ) | XKOS | KR | 2022-12-31 | 3 days ago | KRW | 2,770.00 | 0.00 | 0.00% | 627.56 | 22.66% | Ungraded | 0.00 | 0.00% |